Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Covid Shot Makers Up As J&J CEO Says It May Be Annual Feature

Published 2021-06-09, 12:52 p/m
Updated 2021-06-09, 12:52 p/m
©  Reuters

© Reuters

By Dhirendra Tripathi

Investing.com – Shares of companies making Covid-19 vaccines rose in Wednesday’s trade as CEO of Johnson & Johnson (NYSE:JNJ), one of the firms making the shots, said the jab may be needed every year.

Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) both rose 2%. The former’s vaccine is based on German company BioNTech's proprietary mRNA technology. The two have a tie-up to make and market the vaccine in geographies mutually distributed between the two.

BioNTech (NASDAQ:BNTX) shares were up more than 7%. J&J gained 1%.

CEO Alex Gorsky has spoken about there likely being a need for an annual jab, much like the flu shot.

“We could be looking at this tagging along with the flu shot, likely over the next several years,” he said, referring to the Covid vaccines. He was speaking at The Wall Street Journal’s Tech Health conference.

The U.S. is currently administering only Pfizer, Moderna and J&J vaccines. Elsewhere, vaccines made by Russia’s Gamaleya, the U.K.’s AstraZeneca (NASDAQ:AZN), China’s Sinovac (NASDAQ:SVA) and Sinopharm and India’s Bharat Biotech are being given.

J&J’s is the only vaccine that requires just one jab.

While all vaccines are effective, experts point out that their efficacy wanes over time, and a booster dose may be needed every year.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.